WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience behavioral testing systems
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (24)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by White, M. G.
Right arrow Articles by Meriney, S. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by White, M. G.
Right arrow Articles by Meriney, S. D.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CALCIUM COMPOUNDS
*CALCIUM, ELEMENTAL
*PYRROLE

 Previous Article  |  Next Article 

Volume 17, Number 16, Issue of August 15, 1997 pp. 6302-6313
Copyright ©1997 Society for Neuroscience

Developmental Changes in Calcium Current Pharmacology and Somatostatin Inhibition in Chick Parasympathetic Neurons

Received March 13, 1997; revised May 27, 1997; accepted May 30, 1997.

Michael G. White, Mark A. Crumling, and Stephen D. Meriney

Department of Neuroscience, University of Pittsburgh, Pittsburgh, Pennsylvania 15260

Voltage-dependent calcium (Ca2+) currents were characterized and modulatory effects of somatostatin were measured in acutely dissociated chick ciliary ganglion neurons at embryonic stages 34, 37, and 40. This developmental time period coincides with the period of synapse formation between ciliary ganglion neurons and peripheral eye muscles. At all three developmental stages Ca2+ current could be blocked almost completely by combined application of omega -CgTX GVIA and nitrendipine. At young embryonic ages there was significant overlap in sensitivity, with ~75% of the current sensitive to either blocker applied independently. By stage 40, there was very little or no overlap in sensitivity, with ~75% of the current blocked by omega -CgTX GVIA (N-type) and 30% blocked by nitrendipine (L-type). These data are consistent with earlier findings that the pharmacology of acetylcholine release from ciliary ganglion nerve terminals changes during development from sensitivity to both dihydropyridines and omega -CgTX GVIA to selective sensitivity to omega -CgTX GVIA (). Somatostatin reduced Ca2+ current by 50-60% at all three developmental stages. At early developmental stages somatostatin receptors coupled predominantly to the current that was sensitive to both omega -CgTX GVIA and nitrendipine. By stage 40, somatostatin primarily inhibited classically defined N-type current (selectively sensitive to omega -CgTX GVIA). Thus, somatostatin receptor coupling to Ca2+ channels persisted throughout development as Ca2+ current pharmacology changed.

Key words: calcium channel; somatostatin modulation; development; chick ciliary ganglion; FPL 64176; omega -CgTX GVIA; dihydropyridines




This article has been cited by other articles:


Home page
J. Neurophysiol.Home page
J. D. King Jr. and S. D. Meriney
Proportion of N-Type Calcium Current Activated by Action Potential Stimuli
J Neurophysiol, December 1, 2005; 94(6): 3762 - 3770.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
G. Piccoli, U. Rutishauser, and J. L. Bruses
N-Cadherin Juxtamembrane Domain Modulates Voltage-Gated Ca2+ Current via RhoA GTPase and Rho-Associated Kinase
J. Neurosci., December 1, 2004; 24(48): 10918 - 10923.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
Q. Li, A. Lau, T. J. Morris, L. Guo, C. B. Fordyce, and E. F. Stanley
A Syntaxin 1, G{alpha}o, and N-Type Calcium Channel Complex at a Presynaptic Nerve Terminal: Analysis by Quantitative Immunocolocalization
J. Neurosci., April 21, 2004; 24(16): 4070 - 4081.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
Q.-Q. Sun, J. R. Huguenard, and D. A. Prince
Somatostatin Inhibits Thalamic Network Oscillations In Vitro: Actions on the GABAergic Neurons of the Reticular Nucleus
J. Neurosci., July 1, 2002; 22(13): 5374 - 5386.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
D. E. Artim and S. D. Meriney
G-Protein-Modulated Ca2+ Current With Slowed Activation Does Not Alter the Kinetics of Action Potential-Evoked Ca2+ Current
J Neurophysiol, November 1, 2000; 84(5): 2417 - 2425.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
B. Buchwald, M. de Baets, G.-J. Luijckx, and K. V. Toyka
Neonatal Guillain-Barre syndrome: Blocking antibodies transmitted from mother to child
Neurology, October 1, 1999; 53(6): 1246 - 1246.
[Abstract] [Full Text]


Home page
J. Neurosci.Home page
L. Polo-Parada and G. Pilar
kappa - and µ-Opioids Reverse the Somatostatin Inhibition of Ca2+ Currents in Ciliary and Dorsal Root Ganglion Neurons
J. Neurosci., July 1, 1999; 19(13): 5213 - 5227.
[Abstract] [Full Text] [PDF]



-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2009 by Society for Neuroscience ONLINE ISSN: 1529-2401
-